Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Early signals strengthen ImmVirX case for next generation cancer immunotherapies
April 22, 2026 - - Latest News -
Amplia positions narmafotinib as a potential step change in pancreatic cancer
April 22, 2026 - - Latest News -
Noxopharm advances lupus therapy with data pointing to durable skin targeting and low systemic exposure
April 22, 2026 - -
Invion advances skin cancer trial into largest patient group after encouraging early results
April 22, 2026 - - Latest News -
Trajan taps insider for finance leadership as it navigates transition
April 22, 2026 - -
Recce clears key regulatory hurdle in Indonesia as Phase 3 trial advances toward approval
April 22, 2026 - - Latest News -
Starpharma secures FDA backing as DEP HER2 moves toward first human trial
April 22, 2026 - - Latest News